PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 14, 2026Journal of Clinical Oncology0 citations

Helicobacter pylori and risk of esophageal cancer: A meta-analysis.

View Full Paper
MSMaitri P ShahRSRushi ShahSVSai Sushrutha Mudupula Vemula

Key Points

  • This research aims to clarify the relationship between Helicobacter pylori infection and esophageal cancer, focusing on different histology types.
  • Conducted a systematic literature search across multiple databases up to May 2025.
  • Included observational studies assessing Helicobacter pylori and esophageal cancer associations.
  • Calculated odds ratios and confidence intervals for pooled estimates using random-effects models.
  • Stratified analyses by histology (adenocarcinoma vs squamous cell carcinoma).
  • 43 observational studies were included, with significant finding of reduced overall esophageal cancer risk (OR 0.69).
  • Helicobacter pylori was strongly protective against adenocarcinoma (OR 0.60) but showed no significant association with squamous carcinoma (OR 0.84).
  • Substantial heterogeneity was observed in squamous cell carcinoma studies, indicating inconsistent findings.

Abstract

458 Background: Helicobacter pylori (Hp) is a recognized gastric carcinogen, but its role in esophageal cancer remains uncertain. Previous observational studies have suggested histology-specific effects, with a potential protective association in esophageal adenocarcinoma (EAC) and inconsistent findings in esophageal squamous cell carcinoma (ESCC). We performed a large pooled meta-analysis to clarify these associations. Methods: A systematic literature search was conducted across PubMed, EMBASE, and Google Scholar from inception through May 2025 to identify observational studies evaluating the association between Helicobacter pylori infection and esophageal cancer. Eligible studies were included. Data extraction was performed independently, and odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. Pooled estimates were generated using the Mantel–Haenszel method with random-effects models in RevMan 5.4. Analyses were stratified by histology (EAC vs ESCC), with heterogeneity assessed using I² statistics. Results: A total of 43 observational studies were included, comprising 21 studies of esophageal adenocarcinoma (EAC) and 22 studies of esophageal squamous cell carcinoma (ESCC). When all studies were combined, Hp infection was associated with a significant reduction in overall esophageal cancer risk (pooled OR 0.69, 95% CI 0.64–0.75). In histology-specific analyses, Hp infection demonstrated a strong protective association with EAC (OR 0.60, 95% CI 0.50–0.71; I² = 32%). The forest plot for EAC showed that the majority of studies reported inverse associations, and large population-based datasets contributed heavily to the protective signal. In contrast, ESCC analysis yielded an OR of 0.84 (95% CI 0.64–1.09; I² = 79%), indicating no statistically significant association and substantial heterogeneity. The ESCC forest plot revealed inconsistent findings across geographic regions and study designs, with several series suggesting inverse associations while others reported null effects. Collectively, these results highlight a robust protective effect of Hp in EAC and a weaker, heterogeneous relationship in ESCC. Conclusions: Hp infection appears to play a histology-specific role in esophageal carcinogenesis. In this pooled analysis, Hp was strongly protective against adenocarcinoma but showed no significant association with squamous carcinoma. Further research is required to understand why these effects differ and how eradicating H. pylori might change esophageal cancer risk.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Shah et al. (2026) studied this question.

synapsesocial.com/papers/6966e74713bf7a6f02c000bbhttps://doi.org/10.1200/jco.2026.44.2_suppl.458
Ask AI
Helpful
Bookmark
Share
View Full Paper